Key result
Management of bleeding in patients taking Factor Xa and Factor IIa inhibitors requires specific clinical strategies.
Key points are not available for this paper at this time.
May guide reversal strategies in DOAC bleeding; leaves open need for prospective validation before practice change.
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
No takes yet. Share an insight, caveat, or question.
Keeling et al. (2012) studied this question. Management of bleeding in patients taking Factor Xa and Factor IIa inhibitors requires specific clinical strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: